Argitalpenak (223) SAMUEL NAVARRO FOS argitalpenak

2024

  1. Sarcomas with EWSR1::Non-ETS Fusion (EWSR1::NFATC2 and EWSR1::PATZ1)

    Surgical Pathology Clinics, Vol. 17, Núm. 1, pp. 31-55

  2. Solitary fibrous tumor: Can the new Huang risk stratification system for orbital tumors improve prognostic accuracy in other tumor locations?

    Pathology Research and Practice, Vol. 254

2023

  1. Acquired aggressive multisystemic disseminated lobular capillary haemangioma: a life threatening disorder

    Pathology

  2. Digital image analysis workflows for evaluation of cell behavior and tumor microenvironment to aid therapeutic assessment in high-risk neuroblastoma

    Computers in Biology and Medicine, Vol. 164

  3. Evaluation of Alternative Risk Stratification Systems in a Large Series of Solitary Fibrous Tumors with Molecular Findings and Ki-67 Index Data: Do They Improve Risk Assessment?

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

  4. Extra-meningeal solitary fibrous tumor: an evolving entity with chameleonic morphological diversity, a hallmark molecular alteration and unresolved issues in risk stratification assessment

    Histology and histopathology, Vol. 38, Núm. 10, pp. 1079-1097

  5. Extraskeletal myxoid chondrosarcoma: p53 and Ki-67 offer prognostic value for clinical outcome — an immunohistochemical and molecular analysis of 31 cases

    Virchows Archiv, Vol. 482, Núm. 2, pp. 407-417

  6. Intimal Sarcoma with MDM2/CDK4 Amplification and p16 Overexpression: A Review of Histological Features in Primary Tumor and Xenograft, with Immunophenotype and Molecular Profiling

    International Journal of Molecular Sciences, Vol. 24, Núm. 8

2022

  1. Alveolar rhabdomyosarcoma: Two fusion-negative cases lacking PAX3-FOXO1 and PAX7-FOXO1

    Revista Espanola de Patologia, Vol. 55, Núm. 1, pp. 57-62

  2. Differential diagnosis of myxoid soft tissue tumors. Experience in the Clinical University Hospital of Valencia

    Revista Espanola de Patologia, Vol. 55, Núm. 3, pp. 185-191

  3. Does PAX7 and NKX2.2 immunoreactivity in Ewing sarcoma have prognostic significance?

    Virchows Archiv, Vol. 480, Núm. 4, pp. 909-917

  4. Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness

    Frontiers in Cell and Developmental Biology, Vol. 10

2021

  1. Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma

    Frontiers in Cell and Developmental Biology, Vol. 9

  2. Imbalance between genomic gain and loss identifies high-risk neuroblastoma patients with worse outcomes

    Neoplasia (United States), Vol. 23, Núm. 1, pp. 12-20

  3. Intra-tumour genetic heterogeneity and prognosis in high-risk neuroblastoma

    Cancers, Vol. 13, Núm. 20

  4. Ki-67 immunoexpression and radiological assessment of necrosis improves accuracy of conventional and modified core biopsy systems in predicting the final grade assigned to adult-soft tissue sarcomas. An international collaborative study

    Pathology Research and Practice, Vol. 225

  5. Neuroendocrine differentiation in a large series of genetically-confirmed Ewing's sarcoma family tumor: Does it provide any diagnostic or prognostic information?

    Pathology Research and Practice, Vol. 219

  6. Solitary fibrous tumor: Integration of clinical, morphologic, immunohistochemical and molecular findings in risk stratification and classification may better predict patient outcome

    International Journal of Molecular Sciences, Vol. 22, Núm. 17

  7. Unraveling the extracellular matrix-tumor cell interactions to aid better targeted therapies for neuroblastoma

    International Journal of Pharmaceutics, Vol. 608

  8. Update of the recommendations for the determination of biomarkers in colorectal carcinoma. National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology

    Revista Espanola de Patologia, Vol. 54, Núm. 1, pp. 41-54